[Identification and management of hereditary breast-ovarian cancers (2004 update)]

Area of Science:

• Oncology
• Genetics
• Medical Imaging

Context:

• Extensive literature review with over 2500 new references since the last recommendations.
• Ad Hoc Committee of 13 experts, with revisions by 5 additional experts, ensuring a thorough analysis.

Purpose:

• To update recommendations on breast and ovarian cancer screening and management.
• To evaluate the association between BRCA1/BRCA2 mutations and cancer risk.
• To assess the efficacy and recommendations for screening modalities and prophylactic surgeries.

Summary:

• BRCA1 and BRCA2 mutations may be associated with fewer deleterious mutations in breast and ovarian cancers than previously understood.
• Ovarian cancer screening remains challenging, while MRI is emerging as a recommended option for breast cancer screening in young women with dense breasts.
• The effectiveness of prophylactic surgeries is well-established, with a French recommendation favoring these procedures to maintain quality of life.

Impact:

• Provides updated guidance for healthcare professionals on managing hereditary breast and ovarian cancer risks.
• Highlights the evolving role of MRI in breast cancer screening for specific populations.
• Emphasizes the importance of prophylactic surgeries and quality of life considerations in treatment decisions.